Shufro Rose & CO LLC Gilead Sciences, Inc. Transaction History

Shufro Rose & CO LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $79,021 - $113,447	-1,268 Reduced 27.16%	3,400 $0
Q3 2022 Oct 24, 2022	BUY	$59.54 - $68.01 $1,726 - $1,972	29 Added 0.63%	4,668 $288,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $40,544 - $50,806	-700 Reduced 13.11%	4,639 $276,000
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $33,845 - $36,515	-500 Reduced 8.56%	5,339 $373,000
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $28,325 - $32,275	-500 Reduced 7.89%	5,839 $340,000
Q3 2020 Oct 27, 2020	BUY	$62.1 - $78.08 $1,987 - $2,498	32 Added 0.51%	6,339 $401,000
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $72,846 - $84,588	1,007 Added 19.0%	6,307 $485,000
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $30,810 - $33,890	500 Added 10.42%	5,300 $344,000
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $6,054 - $7,900	-100 Reduced 2.04%	4,800 $300,000
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $973 - $1,135	-15 Reduced 0.31%	4,900 $347,000
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $1,067 - $1,252	15 Added 0.31%	4,915 $352,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $353,339 - $418,803	4,900	4,900 $397,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Shufro Rose & CO LLC with notifications on news.